vs

Side-by-side financial comparison of Live Oak Bancshares, Inc. (LOB) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

Live Oak Bancshares, Inc. is the larger business by last-quarter revenue ($145.5M vs $83.1M, roughly 1.7× PROCEPT BioRobotics Corp). Live Oak Bancshares, Inc. runs the higher net margin — 19.2% vs -38.1%, a 57.3% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 18.4%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 7.7%).

Live Oak Bank, a subsidiary of Live Oak Bancshares, Inc., is an American bank. Headquartered in Wilmington, North Carolina, it serves small business owners in all 50 states and was the leading SBA 7(a) lender by dollar volume in 2022.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

LOB vs PRCT — Head-to-Head

Bigger by revenue
LOB
LOB
1.7× larger
LOB
$145.5M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+1.8% gap
PRCT
20.2%
18.4%
LOB
Higher net margin
LOB
LOB
57.3% more per $
LOB
19.2%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
7.7%
LOB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
LOB
LOB
PRCT
PRCT
Revenue
$145.5M
$83.1M
Net Profit
$27.9M
$-31.6M
Gross Margin
64.9%
Operating Margin
-4.1%
Net Margin
19.2%
-38.1%
Revenue YoY
18.4%
20.2%
Net Profit YoY
187.6%
-27.9%
EPS (diluted)
$0.60
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LOB
LOB
PRCT
PRCT
Q1 26
$145.5M
$83.1M
Q4 25
$161.9M
$76.4M
Q3 25
$146.1M
$83.3M
Q2 25
$143.7M
$79.2M
Q1 25
$126.1M
$69.2M
Q4 24
$116.9M
$68.2M
Q3 24
$129.9M
$58.4M
Q2 24
$125.5M
$53.4M
Net Profit
LOB
LOB
PRCT
PRCT
Q1 26
$27.9M
$-31.6M
Q4 25
$46.2M
$-29.8M
Q3 25
$26.5M
$-21.4M
Q2 25
$23.4M
$-19.6M
Q1 25
$9.7M
$-24.7M
Q4 24
$9.9M
$-18.9M
Q3 24
$13.0M
$-21.0M
Q2 24
$27.0M
$-25.6M
Gross Margin
LOB
LOB
PRCT
PRCT
Q1 26
64.9%
Q4 25
60.6%
Q3 25
64.8%
Q2 25
65.4%
Q1 25
63.9%
Q4 24
64.0%
Q3 24
63.2%
Q2 24
59.0%
Operating Margin
LOB
LOB
PRCT
PRCT
Q1 26
-4.1%
Q4 25
38.2%
-40.6%
Q3 25
25.0%
-27.8%
Q2 25
21.7%
-28.0%
Q1 25
10.4%
-39.7%
Q4 24
11.3%
-28.9%
Q3 24
13.7%
-38.4%
Q2 24
28.7%
-50.3%
Net Margin
LOB
LOB
PRCT
PRCT
Q1 26
19.2%
-38.1%
Q4 25
28.5%
-39.1%
Q3 25
18.1%
-25.7%
Q2 25
16.3%
-24.7%
Q1 25
7.7%
-35.8%
Q4 24
8.5%
-27.6%
Q3 24
10.0%
-35.9%
Q2 24
21.5%
-48.0%
EPS (diluted)
LOB
LOB
PRCT
PRCT
Q1 26
$0.60
$-0.56
Q4 25
$0.96
$-0.54
Q3 25
$0.55
$-0.38
Q2 25
$0.51
$-0.35
Q1 25
$0.21
$-0.45
Q4 24
$0.22
$-0.34
Q3 24
$0.28
$-0.40
Q2 24
$0.59
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LOB
LOB
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$1.3B
$347.7M
Total Assets
$15.3B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LOB
LOB
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$286.5M
Q3 25
$294.3M
Q2 25
$302.7M
Q1 25
$316.2M
Q4 24
$333.7M
Q3 24
$196.8M
Q2 24
$214.1M
Total Debt
LOB
LOB
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
LOB
LOB
PRCT
PRCT
Q1 26
$1.3B
$347.7M
Q4 25
$1.2B
$365.9M
Q3 25
$1.2B
$380.3M
Q2 25
$1.1B
$385.8M
Q1 25
$1.0B
$389.2M
Q4 24
$999.0M
$402.2M
Q3 24
$1.0B
$241.2M
Q2 24
$961.0M
$251.8M
Total Assets
LOB
LOB
PRCT
PRCT
Q1 26
$15.3B
$487.1M
Q4 25
$15.1B
$508.1M
Q3 25
$14.7B
$511.5M
Q2 25
$13.8B
$513.1M
Q1 25
$13.6B
$519.4M
Q4 24
$12.9B
$534.0M
Q3 24
$12.6B
$374.1M
Q2 24
$11.9B
$374.4M
Debt / Equity
LOB
LOB
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LOB
LOB

Segment breakdown not available.

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons